AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,457 | +23.2% | 19,530 | +27.1% | 0.00% | – |
| Q2 2023 | $192,784 | +11.7% | 15,364 | -1.3% | 0.00% | – |
| Q1 2023 | $172,591 | -1.9% | 15,565 | +7.8% | 0.00% | – |
| Q4 2022 | $176,009 | +69.2% | 14,445 | +44.5% | 0.00% | – |
| Q3 2022 | $104,000 | +1.0% | 9,997 | +3.9% | 0.00% | – |
| Q2 2022 | $103,000 | +17.0% | 9,618 | +2.8% | 0.00% | – |
| Q1 2022 | $88,000 | -20.0% | 9,359 | -1.6% | 0.00% | – |
| Q4 2021 | $110,000 | +57.1% | 9,516 | +30.4% | 0.00% | – |
| Q3 2021 | $70,000 | -17.6% | 7,299 | -17.5% | 0.00% | – |
| Q2 2021 | $85,000 | -26.7% | 8,851 | -24.4% | 0.00% | – |
| Q1 2021 | $116,000 | +63.4% | 11,712 | +279.3% | 0.00% | – |
| Q4 2020 | $71,000 | +57.8% | 3,088 | +0.4% | 0.00% | – |
| Q3 2020 | $45,000 | +87.5% | 3,077 | +106.8% | 0.00% | – |
| Q2 2020 | $24,000 | +50.0% | 1,488 | -18.8% | 0.00% | – |
| Q1 2020 | $16,000 | – | 1,832 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |